Vir Biotechnology, Inc. (VIR)
USD 7.16
(-2.65%)
USD 7.16
(-2.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -778.78 Million | 1.66 Billion | -47.58 Million | -190.94 Million | -129.63 Million | -94.09 Million |
| Net Income | -615.06 Million | 515.83 Million | 528.58 Million | -298.66 Million | -174.68 Million | -115.88 Million |
| Depreciation & Amortization | 19.45 Million | 6.78 Million | 5.81 Million | 5.44 Million | 4.51 Million | 2.75 Million |
| Deferred income taxes | -1.06 Million | -15.18 Million | 15.18 Million | -52 Thousand | 14.66 Million | -480 Thousand |
| Stock-based compensation | 111.31 Million | 102.08 Million | 83.78 Million | 27.6 Million | 8.71 Million | 5.05 Million |
| Change in working capital | -304.59 Million | 665.36 Million | -628.39 Million | 29.52 Million | 8.2 Million | 12.49 Million |
| Other non-cash items | 11.16 Million | 388.37 Million | -52.56 Million | 45.21 Million | 8.94 Million | 1.96 Million |
| Investing Cash Flow | 164.72 Million | -1.19 Billion | -140.81 Million | -9.86 Million | -256.15 Million | -60.44 Million |
| Investments in PPE | -21.57 Million | -68.02 Million | -21.81 Million | -6.54 Million | -8.94 Million | -8.19 Million |
| Acquisitions | 100 Thousand | 22 Thousand | 140.81 Million | 180 Thousand | 247.21 Million | 25 Thousand |
| Investment purchases | -2.01 Billion | -1.47 Billion | -420.24 Million | -403.84 Million | -643.89 Million | -123.1 Million |
| Sales/Maturities of investments | 2.2 Billion | 351.51 Million | 301.24 Million | 400.34 Million | 396.68 Million | 72.57 Million |
| Other Investing Activities | 186.2 Million | -1.12 Billion | -140.81 Million | 180 Thousand | -247.21 Million | -1.74 Million |
| Financing Cash Flow | 7.38 Million | 34.76 Million | 100.33 Million | 529.47 Million | 449.24 Million | 24.97 Million |
| Debt repayment | -287 Thousand | -260 Thousand | -259 Thousand | -250 Thousand | -95 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 3.22 Million | - | - | -3000.00 | - |
| Common Stock Issuance | 7.76 Million | 36.21 Million | 100.59 Million | 529.91 Million | 126.41 Million | 24.97 Million |
| Other Financing Activities | -100 Thousand | 35.02 Million | 100.59 Million | -189 Thousand | 322.93 Million | 24.97 Million |
| Accounts receivables | -565 Thousand | 770.03 Million | -773.07 Million | - | - | - |
| Accounts payables | 732 Thousand | 797 Thousand | -171 Thousand | -790 Thousand | 964 Thousand | 1.47 Million |
| Inventory | - | - | 52.81 Million | - | - | - |
| Other working capital | -304.75 Million | -105.46 Million | 92.04 Million | 30.31 Million | 7.24 Million | 11.02 Million |
| Cash at beginning of period | 861.31 Million | 363.41 Million | 451.48 Million | 122.81 Million | 59.36 Million | 188.92 Million |
| Cash at end of period | 254.84 Million | 867.96 Million | 363.41 Million | 451.48 Million | 122.81 Million | 59.36 Million |
| Capital Expenditure | -21.57 Million | -68.02 Million | -21.81 Million | -6.54 Million | -8.94 Million | -8.19 Million |
| Effect of forex changes on cash | -7.48 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -606.46 Million | 504.55 Million | -88.07 Million | 328.67 Million | 63.45 Million | -129.55 Million |
| Free Cash Flow | -800.35 Million | 1.59 Billion | -69.4 Million | -197.49 Million | -138.57 Million | -102.28 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -213.71 Million | -138.37 Million | -65.27 Million | -615.06 Million | -115.97 Million | -163.41 Million |
| Depreciation & Amortization | 6.12 Million | 4.26 Million | 4.51 Million | 19.45 Million | 4.47 Million | 4.58 Million |
| Deferred income taxes | 57 Thousand | -363 Thousand | - | -1.06 Million | -1.06 Million | -166.62 Million |
| Stock-based compensation | 16.69 Million | 22.16 Million | 23.75 Million | 111.31 Million | 28.27 Million | 26.94 Million |
| Change in working capital | 84.49 Million | -2.35 Million | -82.14 Million | -304.59 Million | -32.74 Million | -29.69 Million |
| Other non-cash items | -65.14 Million | 67.71 Million | 42.21 Million | 11.16 Million | 9.1 Million | 172.37 Million |
| Investing Cash Flow | 118.6 Million | 211.6 Million | 28.42 Million | 164.72 Million | -104.81 Million | -58.95 Million |
| Investments in PPE | -2.35 Million | -666 Thousand | -1.87 Million | -21.57 Million | -1.53 Million | -3.71 Million |
| Acquisitions | -912 Thousand | 379 Thousand | 533 Thousand | 100 Thousand | 184.43 Million | 55.24 Million |
| Investment purchases | -240.14 Million | -271.4 Million | -562.93 Million | -2.01 Billion | -818.99 Million | -502.91 Million |
| Sales/Maturities of investments | 361.5 Million | 483.29 Million | 592.69 Million | 2.2 Billion | 715.71 Million | 447.67 Million |
| Other Investing Activities | 505 Thousand | 212.27 Million | 533 Thousand | 186.2 Million | -184.43 Million | -55.24 Million |
| Financing Cash Flow | 31 Thousand | 2.94 Million | 152 Thousand | 7.38 Million | 1.68 Million | 277 Thousand |
| Debt repayment | -40 Thousand | -69 Thousand | -69 Thousand | -287 Thousand | -87 Thousand | -66 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -630 Thousand | 3.01 Million | 221 Thousand | 7.76 Million | 1.76 Million | 343 Thousand |
| Other Financing Activities | 701 Thousand | 3.01 Million | 221 Thousand | -100 Thousand | 400 Thousand | 277 Thousand |
| Accounts receivables | -2.28 Million | 2.68 Million | -401 Thousand | -565 Thousand | -3.6 Million | -3.04 Million |
| Accounts payables | 3.1 Million | -2.89 Million | 735 Thousand | 732 Thousand | 2.62 Million | -7.52 Million |
| Inventory | - | - | - | - | 248.31 Million | 3.04 Million |
| Other working capital | 84.62 Million | -2.14 Million | -82.48 Million | -304.75 Million | -280.08 Million | -22.16 Million |
| Cash at beginning of period | 310.81 Million | 174.04 Million | 254.84 Million | 861.31 Million | 465.29 Million | 686.85 Million |
| Cash at end of period | 264.33 Million | 310.81 Million | 174.04 Million | 254.84 Million | 254.84 Million | 472.35 Million |
| Capital Expenditure | -2.35 Million | -666 Thousand | -1.87 Million | -21.57 Million | -1.53 Million | -3.71 Million |
| Effect of forex changes on cash | - | - | - | -7.48 Million | -47.88 Million | 47.88 Million |
| Net cash flow / Change in cash | -46.48 Million | 136.76 Million | -80.79 Million | -606.46 Million | -210.44 Million | -214.5 Million |
| Free Cash Flow | -173.83 Million | -78.51 Million | -111.26 Million | -800.35 Million | -109.46 Million | -159.54 Million |
VNNVF
NEFB
CBRE
CHAMBLFERT
600796
GDPHF